Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $0.01 USD
Change Today 0.00 / 0.00%
Volume 0.0
OHAQ On Other Exchanges
As of 8:10 PM 08/11/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Joel D. Liffmann

AgeTotal Calculated CompensationThis person is connected to 25 board members in 4 different organizations across 7 different industries.

See Board Relationships


Mr. Joel D. Liffmann has been Senior Vice President of Finance at Intrexon Corporation since July 2015. Mr. Liffmann has been a Senior Advisor at Vestar Capital Partners for several years. Mr. Liffmann is an Investment Partner at Oracle Investment Management, Inc. He has been a Partner at Oracle Partners, LP specializing in public securities investing and merchant banking in health care, bioscience, and related industries. He has over thirty years of public and private ...

Read Full Background

Corporate Headquarters*

200 Greenwich Avenue
Greenwich, Connecticut 06830

United States

Phone: 203-862-7900
Fax: --

Board Members Memberships*

Founder and Director


BS 1982
Boston University

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
OHAQ:US $0.01 USD 0.00


John W. Varian Chief Executive Officer and Director
XOMA Corporation
Simon E. Moroney Ph.D.Chairman of Management Board and Chief Executive Officer
Morphosys AG
Charles G. Marianik Chairman of the Board, Chief Executive Officer and President
Horiba Scientific
David L. Hallal Chief Executive Officer and Director
Alexion Pharmaceuticals, Inc.
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ORACLE HEALTHCARE ACQUISIT, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at